Here are relevant reports on : anxiety-disorders-therapeutics-market
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
Disposable Medical Device Sensors Market by Product (Biosensor, Image sensor, Accelerometer), Type (Strip Sensors, Invasive Sensors, Wearable Sensors), Application(Diagnostic Testing, Therapeutics, Patient Monitoring, Imaging) - Global Forecast to 2026
The global disposable medical device sensors market in terms of revenue was estimated to be worth $6.5 billion in 2021 and is poised to reach $9.4 billion by 2026, growing at a CAGR of 7.7% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application [Diagnostics (Clinical, PoC), Research (Proteomics, Genomics, Cell), Therapeutics (Drug Delivery Wearables)], End User – Global forecast to 2030
The global Microfluidics market, valued at US$23.71 billion in 2024, stood at US$24.96 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$37.19 billion by the end of the period. Several significant factors are driving the growth of the microfluidics market, thereby enhancing its expansion and applications. There is a growing demand for point-of-care diagnostics, which require fast, accurate, and cost-effective instruments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Spine MRI System Market by Component (Magnet, RF Coil, Cooling System, Shim System), Field Strength (1.5T, 3T, 7T), Application (Spine Disorders, Fractures, Spine Tumors, Presurgical Planning), Installed Base & Replacement Rate - Global Forecast to 2031
The Spine MRI System market, valued at USD0.70 billion in 2025, stood at USD0.74 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of USD1.07 billion by the end of the period. The market is driven by the rapidly increasing geriatric population and the corresponding rise in spine-related degenerative diseases such as spinal stenosis and disc herniation; a growing focus on replacing low-field MRI systems with high-field systems to improve spine imaging accuracy; increasing demand for early diagnosis of spinal conditions and expanding clinical applications, including spine trauma, tumors, and neurological disorders; ongoing technological advancements in spine MRI modalities; and rising investments, funding, and grants from public-private organizations to enhance spine imaging capabilities.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024
The leukemia therapeutics market is projected to reach USD 17.1 billion by 2024, at a CAGR of 6.8%. Market growth is largely driven by the rising prevalence of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) and increasing approvals of novel & innovative drugs and immunotherapies. The major players in this market are AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland, F. Hoffmann-La Roche (Switzerland), Pfizer (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Takeda Pharmaceutical (Japan), and Celgene (US). Product approvals are a key strategy adopted by key players in order to enhance their dominance in this market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Adipose Derived Stem Cell Market by Type (Autologous, Allogeneic), Product (Cell Line. Culture Media), Disease (CVS, CNS, MSK, Obesity, Cancer), End User (Hospitals, Tissue Banks, Academia), Application (Therapeutics, Research) - Global Forecasts to 2019
Emerging markets including China, India, South Korea, and Brazil have become attractive destinations for companies engaged in the development and manufacturing of adipose derived stem cell products. A number of factors such as growing preference for use of adipose derived stem cells in therapeutics and emerging markets offering low regulatory barriers for conducting clinical studies are offering new growth opportunities for players active in the global adipose derived stem cell market
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Automotive Seating Systems Market-Trends and forecast
This report is a professional and in-depth study on current state of the Automotive Seating Systems market. The report provides key statistics on the market status and is a valuable source of guidance and direction for companies and individuals interested in this industry. The report also covers competitive landscape, recent developments and strategies for major players in this market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
AR and VR Display Market by Device Type (AR HMDs, VR HMDs, AR HUDs, VR Projectors), Technology, Display Technology (LCD, OLED, Micro-LED), Application (Consumer, Commercial, Enterprise, Healthcare, Aerospace & Defense) & Region - Global Forecast to 2028
The global AR and VR display market is expected to grow from USD 1.8 billion in 2023 to USD 8.2 billion by 2028, at a compound annual growth rate (CAGR) of 35.6% during the forecast period.The Key Players Samsung Electronics (South Korea), Sony (Japan), LG Display (South Korea), eMagin Corporation (US), Kopin Corporation (US), AU Optronics (Taiwan), Japan Display (Japan), Barco (Belgium), BOE Technology (China), and Syndiant (US)
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Services NDT and Inspection Market by Inspection Service, Equipment Rental Services, Calibration Service, Visual Inspection, Surface Inspection, Volumetric Inspection, Automotive, Aerospace, and Oil & Gas - Global Forecast to 2030
The services NDT and inspection market is expected to grow from USD 11.41 billion in 2025 to USD 17.31 billion by 2030, at a CAGR of 8.7% from 2025 to 2030. The Key Players SGS Société Générale de Surveillance SA (SGS SA) (Switzerland), Bureau Veritas (France), Baker Hughes Company (US), Applus+ (Spain), and Intertek Group plc (UK).
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
